Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • New & Views
  • Published:

Paediatrics

New cryptorchidism guidelines reach a consensus

Nature Reviews Urology volume 11, pages 432–433 (2014)Cite this article

Subjects

The American Urological Association has released a new guideline on the evaluation and treatment of cryptorchidism, recommending early orchiopexy as the first-line treatment for both the congenital and acquired forms of the disease; hormonal therapy is not recommended. Given similarities with current European recommendations, transatlantic consensus has been achieved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bay, K., Main, K. M., Toppari, J. & Skakkebæk, N. E. Testicular descent: INSL3, testosterone, genes and the intrauterine milieu. Nat. Rev. Urol. 8, 187–196 (2011).

    Article  CAS  Google Scholar 

  2. Kolon, T. F. et al. Evaluation and treatment of cryptorchidism: AUA guideline. J. Urol. 192, 337–345 (2014).

    Article  Google Scholar 

  3. Tekgül, S. et al. Guidelines on Pediatric Urology. European Association of Urology [online], (2014).

    Google Scholar 

  4. Ritzén, E. M. et al. Nordic consensus on treatment of undescended testes. Acta Paediatr. 96, 638–643 (2007).

    Article  Google Scholar 

  5. Gapany, C. et al. Management of cryptorchidism in children: guidelines. Swiss Med. Wkly 138, 492–498 (2008).

    PubMed  Google Scholar 

  6. van der Plas, E. M. et al. Long-term testicular volume after orchiopexy at diagnosis of acquired undescended testis. J. Urol. 190, 257–262 (2013).

    Article  Google Scholar 

  7. Kollin, C., Hesser, U., Ritzén, E. M. & Karpe, B. Testicular growth from birth to two years of age, and the effect of orchidopexy at age nine months: a randomized, controlled study. Acta Paediatr. 95, 318–324 (2006).

    Article  Google Scholar 

  8. Cortes, D., Thorup, J. & Visfeldt, J. Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism. J. Urol. 163, 1290–1292 (2000).

    Article  CAS  Google Scholar 

  9. Schwentner, C. et al. Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial. J. Urol. 173, 974–977 (2005).

    Article  CAS  Google Scholar 

  10. Toppari, J., Virtanen, H. E., Main, K. M. & Skakkebæk, N. E. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res. A Clin. Mol. Teratol. 88, 910–919 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Physiology and Pediatrics, University of Turku and Turku University Hospital, Kiinamyllynkatu 10, Turku, FI-20520, Finland

    Jorma Toppari

Authors
  1. Jorma Toppari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorma Toppari.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toppari, J. New cryptorchidism guidelines reach a consensus. Nat Rev Urol 11, 432–433 (2014). https://doi.org/10.1038/nrurol.2014.180

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2014.180

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing